These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28468594)

  • 21. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.
    Buchwalter G; Hickey MM; Cromer A; Selfors LM; Gunawardane RN; Frishman J; Jeselsohn R; Lim E; Chi D; Fu X; Schiff R; Brown M; Brugge JS
    Cancer Cell; 2013 Jun; 23(6):753-67. PubMed ID: 23764000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
    Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
    Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
    Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
    Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
    Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK
    Cancer Res; 2003 Aug; 63(15):4626-31. PubMed ID: 12907642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
    Ghadersohi A; Odunsi K; Zhang S; Azrak RG; Bundy BN; Manjili MH; Li F
    Int J Cancer; 2008 Sep; 123(6):1376-84. PubMed ID: 18567002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
    Ghadersohi A; Odunsi K; Lele S; Collins Y; Greco WR; Winston J; Liang P; Sood AK
    Oncol Rep; 2004 Feb; 11(2):453-8. PubMed ID: 14719083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer.
    Cao L; Xiang G; Liu F; Xu C; Liu J; Meng Q; Lyu S; Wang S; Niu Y
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):609-620. PubMed ID: 31297554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.
    Scheiber MN; Watson PM; Rumboldt T; Stanley C; Wilson RC; Findlay VJ; Anderson PE; Watson DK
    Neoplasia; 2014 Oct; 16(10):801-13. PubMed ID: 25379017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells.
    Thompson HG; Harris JW; Wold BJ; Lin F; Brody JP
    Oncogene; 2003 Apr; 22(15):2322-33. PubMed ID: 12700667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
    Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
    Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
    Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
    DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
    Kim IJ; Kang TW; Jeong T; Kim YR; Jung C
    Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
    Pal M
    J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer.
    Deves C; Renck D; Garicochea B; da Silva VD; Giulianni Lopes T; Fillman H; Fillman L; Lunardini S; Basso LA; Santos DS; Batista EL
    Virchows Arch; 2011 Apr; 458(4):421-30. PubMed ID: 21318373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
    Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK
    Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDEF and PDEF-induced proteins as candidate tumor antigens for T cell and antibody-mediated immunotherapy of breast cancer.
    Sood AK
    Immunol Res; 2010 Mar; 46(1-3):206-15. PubMed ID: 19763888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile of Ets gene expression in human breast carcinoma.
    He J; Pan Y; Hu J; Albarracin C; Wu Y; Dai JL
    Cancer Biol Ther; 2007 Jan; 6(1):76-82. PubMed ID: 17172821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the 2.0 A crystal structure of the protein-DNA complex of the human PDEF Ets domain bound to the prostate specific antigen regulatory site.
    Wang Y; Feng L; Said M; Balderman S; Fayazi Z; Liu Y; Ghosh D; Gulick AM
    Biochemistry; 2005 May; 44(19):7095-106. PubMed ID: 15882048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.
    Turner DP; Findlay VJ; Kirven AD; Moussa O; Watson DK
    Mol Biol Cell; 2008 Sep; 19(9):3745-57. PubMed ID: 18579687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.